Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PYRANTEL EMBONATE CRS (20 MG)

PYRANTEL EMBONATE CRS (20 MG)

22204-24-6

DISCOVER
PYRANTEL IMPURITY A CRS (20 MG)

PYRANTEL IMPURITY A CRS (20 MG)

NA

DISCOVER
OXELADIN IMPURITY C CRS (15 MG)

OXELADIN IMPURITY C CRS (15 MG)

NA

DISCOVER
SALICYLIC ACID IMPURITY B CRS(15 MG)

SALICYLIC ACID IMPURITY B CRS(15 MG)

636-46-4

DISCOVER
IOPAMIDOL IMPURITY H CRS (15 MG)

IOPAMIDOL IMPURITY H CRS (15 MG)

NA

DISCOVER
METHYLROSANILINIUM FOR SYSTEMSUITABILITY CRS (10 MG)

METHYLROSANILINIUM FOR SYSTEMSUITABILITY CRS (10 MG)

548-62-9

DISCOVER
STAVUDINE CRS (100 MG)

STAVUDINE CRS (100 MG)

3056-17-5

DISCOVER
FAMOTIDINE IMPURITY D CRS (15MG)

FAMOTIDINE IMPURITY D CRS (15MG)

NA

DISCOVER
NALTREXONE IMPURITY C CRS (15MG)

NALTREXONE IMPURITY C CRS (15MG)

NA

DISCOVER
SULFAMETHOXAZOLE IMPURITY A CRS (5 MG)

SULFAMETHOXAZOLE IMPURITY A CRS (5 MG)

21312-10-7

DISCOVER
SULFAMETHOXAZOLE IMPURITY F CRS (15 MG)

SULFAMETHOXAZOLE IMPURITY F CRS (15 MG)

NA

DISCOVER
TIAMULIN FOR PEAK IDENTIFICATION CRS (10 MG)

TIAMULIN FOR PEAK IDENTIFICATION CRS (10 MG)

55297-96-6

DISCOVER